Suppr超能文献

微小RNA-21通过靶向视网膜母细胞瘤中的PDCD4下调Rb1表达。

MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma.

作者信息

Shen Fengmei, Mo Meng-Hsuan, Chen Liang, An Shejuan, Tan Xiaohui, Fu Yebo, Rezaei Katayoon, Wang Zuoren, Zhang Lin, Fu Sidney W

机构信息

1. Department of Ophthalmology, Xi'an Jiaotong University First Affiliated Hospital, Xi'an, China.

2. Department of Medicine, Division of Genomic Medicine, and Department of Microbiology, Immunology and Tropical Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

出版信息

J Cancer. 2014 Nov 21;5(9):804-12. doi: 10.7150/jca.10456. eCollection 2014.

Abstract

Retinoblastoma (RB) is a children's ocular cancer caused by mutated retinoblastoma 1 (Rb1) gene on both alleles. Rb1 and other related genes could be regulated by microRNAs (miRNA) via complementarily pairing with their target sites. MicroRNA-21 (miR-21) possesses the oncogenic potential to target several tumor suppressor genes, including PDCD4, and regulates tumor progression and metastasis. However, the mechanism of how miR-21 regulates PDCD4 is poorly understood in RB. We investigated the expression of miRNAs in RB cell lines and identified that miR-21 is one of the most deregulated miRNAs in RB. Using qRT-PCR, we verified the expression level of several miRNAs identified by independent microarray assays, and analyzed miRNA expression patterns in three RB cell lines, including Weri-Rb1, Y79 and RB355. We found that miR-19b, -21, -26a, -195 and -222 were highly expressed in all three cell lines, suggesting their potential role in RB tumorigenesis. Using the TargetScan program, we identified a list of potential target genes of these miRNAs, of which PDCD4 is one the targets of miR-21. In this study, we focused on the regulatory mechanism of miR-21 on PDCD4 in RB. We demonstrated an inverse correlation between miR-21 and PDCD4 expression in Weri-Rb1 and Y79 cells. These data suggest that miR-21 down-regulates Rb1 by targeting PDCD4 tumor suppressor. Therefore, miR-21 could serve as a therapeutic target for retinoblastoma.

摘要

视网膜母细胞瘤(RB)是一种儿童眼部癌症,由两个等位基因上的视网膜母细胞瘤1(Rb1)基因突变引起。Rb1和其他相关基因可通过与靶位点互补配对受到微小RNA(miRNA)的调控。微小RNA-21(miR-21)具有靶向包括PDCD4在内的多个肿瘤抑制基因的致癌潜力,并调节肿瘤的进展和转移。然而,在RB中,miR-21如何调控PDCD4的机制尚不清楚。我们研究了RB细胞系中miRNA的表达,发现miR-21是RB中失调最严重的miRNA之一。使用qRT-PCR,我们验证了通过独立微阵列分析鉴定的几种miRNA的表达水平,并分析了三种RB细胞系(包括Weri-Rb1、Y79和RB355)中的miRNA表达模式。我们发现miR-19b、-21、-26a、-195和-222在所有三种细胞系中均高表达,表明它们在RB肿瘤发生中具有潜在作用。使用TargetScan程序,我们确定了这些miRNA的潜在靶基因列表,其中PDCD4是miR-21的靶标之一。在本研究中,我们重点关注miR-21对RB中PDCD4的调控机制。我们证明了Weri-Rb1和Y79细胞中miR-21与PDCD4表达呈负相关。这些数据表明,miR-21通过靶向肿瘤抑制因子PDCD4下调Rb1。因此,miR-21可作为视网膜母细胞瘤的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d902/4263991/3fdd51f89b74/jcav05p0804g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验